Driving Innovation

Creating the Conditions for Breakthrough Science

Innovation at Fred Hutch is supported by a suite of services and programs that accelerate discoveries and help speed their path from the research lab to the patient’s bedside. Our investigators and research partners have access to specialized facilities and equipment, integrated research centers, and powerful data science infrastructure and computational guidance.

15

shared resources and scientific services

Our cutting-edge shared resources include specialized equipment and unrivaled expertise to support basic, translational, clinical and public health studies.

#1

recipient of NIH funding

We receive more than $345 million annually in research grants and contracts among independent U.S. research institutions.

322

active inventions

We have a rich pipeline of inventions, programs and projects with promise for commercialization.

33

companies founded based on our research

Fred Hutch is a leader in the commercialization of oncologic innovations, in partnership with pharma, biotech and venture capital partners.

A Suite of Services and Facilities

Genomics researchers at Fred Hutchinson Cancer Research Center.

Shared Resources

We maintain specialized labs and equipment that are available for use by all Fred Hutch investigators as well as our fellow Cancer Consortium members (University of Washington, Seattle Children’s and Seattle Cancer Care Alliance) and the wider academic and biotechnology community.

The Cell Processing facility at Fred Hutchinson Cancer Research Center.

GMP Manufacturing / Cell Processing

We maintain a state-of-the-art facility that produces high-quality stem cell products for clinical trial use in accordance with the FDA’s Good Manufacturing Practice (GMP) regulations.

Raphael Gottardo speaking at Fred Hutch's Immunotherapy Integrated Research Center faculty retreat.

Team Science

Our integrated research centers bring together top-caliber scientists from multiple disciplines to bridge the gap between basic research and translational research, with the goal of bringing high-impact solutions to market.

Michael Zager demonstrates Oncoscape for a colleague at the 2017 Seattle Translational Tumor Research Precision Medicine retreat.

Data-Intensive Bioscience

We provide our investigators with access to powerful data science infrastructure and support so they can make the best use of their large data sets.

We’re Always Seeking Connections to Help Cure Cancer

Partner With Us